Coreg Articles

Boeh Mannheim's Carvedilol Approved In Germany

26 March 1997

Carvedilol Backed For Heart Failure In USA

10 March 1997

New Products Drive Strong Growth At SB

24 February 1997

Analysts Cast Doubt On Kredex' Potential In USA

17 February 1997

Boeh Mannnheim's Carvedilol Approved In Austria

10 February 1997

Continued Approval Of Blockbuster Products In '97?

23 December 1996

SmithKline Beecham 3rd Qtr Earnings Leap 20%

28 October 1996

Canada Clears SB And BMT's Coreg

14 October 1996

Second Heart Failure Launch For Carvedilol

16 September 1996

First Launch Of Carvedilol For CHF; Approval In Spain

2 September 1996

SmithKline Beecham: A Leader In Spanish Market

19 August 1996

European and London Stock Market

17 June 1996

Europe Stock Comment

13 May 1996

SB Fails To Get CHF Backing For Carvedilol

13 May 1996

New Cardiovascular Drugs Reviewed

6 May 1996

SB Trading Profit Up 19% On New Prods

26 February 1996

First Launch Of SB's Carvedilol For Heart Failure

29 January 1996

Astra Merck Gets Bucindolol Rights

18 December 1995

UK Prescription Medicine Code Of Practice Review

4 December 1995

EUROPE STOCK COMMENT

20 November 1995

SB's Carvedilol Cuts CHF Deaths By 67%, AHA Told

20 November 1995

SmithKline Beecham/ Boeh Mannheim: carvedilol

16 October 1995

SmithKline Beecham Unveils Power Pipeline

9 October 1995

SmithKline Beecham's Coreg Approved For Hypertension In The USA

25 September 1995

SB's Carvedilol Effective In Congestive Heart Failure

13 February 1995

Highlights Of SmithKline's R&D Portfolio

2 January 1995

CORANGE 2000: A REVIEW AND FUTURE STRATEGY

11 July 1994

DAIICHI ENTERING NEW PRODUCT PHASE

26 July 1993

DAIICHI LAUNCHES ONCE-DAILY ARTIST

7 June 1993

NEW PRODUCTS ON JAPAN TARIFF LIST

12 April 1993

US CARVEDILOL NDA "IMMINENT," SAYS SB

15 February 1993

Daiichi expects improvement in 92

22 June 1992

NEW CHEMICAL ENTITIES UPDATE FOR 1991

10 February 1992

Showing 101-133 of 133 articles

Go to beginningPreviousNextGo to end